Resources for Life Sciences Leaders Navigating COVID-19 Business Disruption
The COVID-19 pandemic has introduced unprecedented challenges for pharmaceutical and biotechnology leaders, as your organizations rapidly pivot to develop lifesaving products while preserving day-to-day business operations. We are grateful for the efforts you and your organizations are spearheading during this critical time.
Below you’ll find a collection of educational resources to help you address the most pressing challenges life sciences organizations are facing as a result of COVID-19. We encourage you to connect with us if you need immediate assistance.
Find out the stimulus resources available to your organization. Read more.
Digital Risk Minimization
- Client Alert: FDA Issues Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Pandemic
- Expect the Unexpected: How Leaders can Evolve Their Organizational Culture in Turbulent Times
- Guidelines to Maximize Liquidity and Support a Cash-Centric Organization During Market Uncertainty
- Liquidity in Crisis: Why Thinking Like a Startup Can Help Businesses Recover
Receive the latest insights and news from Huron’s transformation experts.